(Q38113105)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23748591%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

title

3rd Brazilian Consensus on Helicobacter pylori (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23748591%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

0 references

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23748591%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

author name string

Ismael Maguinilk

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23748591%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

Schlioma Zaterka

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23748591%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

José Miguel Parente

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23748591%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

Maria do Carmo Friche Passos

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23748591%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

Joaquim Prado P Moraes-Filho

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23748591%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

publication date

19 April 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23748591%20AND%20SRC:MED&resulttype=core&format=json

Arquivos de Gastroenterologia

2 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23748591%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

volume

50

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23748591%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23748591%20AND%20SRC:MED&resulttype=core&format=json

Prevalence and risk factors associated with Helicobacter pylori infection in native populations from Brazilian Western Amazon

2 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1590%2FS0004-28032013005000001

Host-bacterial interactions in Helicobacter pylori infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-28032013005000001

Platelet count response to H. pylori treatment in patients with immune thrombocytopenic purpura with and without H. pylori infection: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-28032013005000001

Efficacy and safety of Levofloxacin, Clarithromycin and Esomeprazol as first line triple therapy for Helicobacter pylori eradication in Middle East. Prospective, randomized, blind, comparative, multicenter study

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-28032013005000001

Antioxidant supplements for prevention of gastrointestinal cancers: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-28032013005000001

H. pylori Infection Is a Key Risk Factor for Proximal Gastric Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-28032013005000001

Helicobacter pylori colonization among children up to 6 years: results of a community-based study from Northeastern Brazil

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-28032013005000001

Is Helicobacter pylori infection a necessary condition for noncardia gastric cancer?

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-28032013005000001

Adherence to a Mediterranean diet and risk of gastric adenocarcinoma within the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-28032013005000001

Nitrofuran-based regimens for the eradication of Helicobacter pylori infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-28032013005000001

First-line eradication of Helicobacter pylori: are the standard triple therapies obsolete? A different perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-28032013005000001

Helicobacter felis eradication restores normal architecture and inhibits gastric cancer progression in C57BL/6 mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-28032013005000001

A meta-analysis of short versus long therapy with a proton pump inhibitor, clarithromycin and either metronidazole or amoxycillin for treating Helicobacter pylori infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-28032013005000001

Gastric MALT lymphoma: epidemiology and high adenocarcinoma risk in a nation-wide study

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-28032013005000001

Preventing recurrent upper gastrointestinal bleeding in patients with Helicobacter pylori infection who are taking low-dose aspirin or naproxen

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-28032013005000001

Eradication of Helicobacter pylori and risk of peptic ulcers in patients starting long-term treatment with non-steroidal anti-inflammatory drugs: a randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-28032013005000001

Comparison of the once-daily levofloxacin-containing triple therapy with the twice-daily standard triple therapy for first-line Helicobacter pylori eradication: a prospective randomised study

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-28032013005000001

Latin-American Consensus Conference on Helicobacter pylori infection. Latin-American National Gastroenterological Societies affiliated with the Inter-American Association of Gastroenterology (AIGE).

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-28032013005000001

New once-daily, highly effective rescue triple therapy after multiple Helicobacter pylori treatment failures: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-28032013005000001

Omeprazole, clarithromycin and furazolidone for the eradication of Helicobacter pylori in patients with duodenal ulcer

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-28032013005000001

Seroprevalence and potential risk factors for Helicobacter pylori infection in Brazilian children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-28032013005000001

Review article: Helicobacter pylori eradication for the prevention of gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-28032013005000001

Helicobacter pylori eradication and gastric cancer: when is the horse out of the barn?

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-28032013005000001

Initial management strategies for dyspepsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-28032013005000001

Management of precancerous conditions and lesions in the stomach (MAPS): guideline from the European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter Study Group (EHSG), European Society of Pathology (ESP), and the Sociedade Portu

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-28032013005000001

The functional gastrointestinal disorders and the Rome III process

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-28032013005000001

Efficacy of a 7-day course of furazolidone, levofloxacin, and lansoprazole after failed Helicobacter pylori eradication

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-28032013005000001

Helicobacter pylori antibiotic resistance in Brazil: clarithromycin is still a good option.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-28032013005000001

Helicobacter pylori in gastric cancer established by CagA immunoblot as a marker of past infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-28032013005000001

The association between Helicobacter pylori infection and height in children from an urban community in north-east Brazil

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-28032013005000001

Younger siblings play a major role in Helicobacter pylori transmission among children from a low-income community in the Northeast of Brazil

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-28032013005000001

A randomized clinical trial to determine the efficacy of regimens containing clarithromycin, metronidazole, and amoxicillin among histologic subgroups for Helicobacter pylori eradication in a developing country

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-28032013005000001

Asia-Pacific consensus guidelines on gastric cancer prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-28032013005000001

How can the current strategies for Helicobacter pylori eradication therapy be improved?

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-28032013005000001

Effect of Helicobacter pylori eradication on platelet count in idiopathic thrombocytopenic purpura: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-28032013005000001

Helicobacter pylori eradication using tetracycline and furazolidone versus amoxicillin and azithromycin in lansoprazole based triple therapy: an open randomized clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-28032013005000001

Meta-analysis: duration of first-line proton-pump inhibitor based triple therapy for Helicobacter pylori eradication

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-28032013005000001

Meta-analysis: can Helicobacter pylori eradication treatment reduce the risk for gastric cancer?

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-28032013005000001

Effect of eradication of Helicobacter pylori on incidence of metachronous gastric carcinoma after endoscopic resection of early gastric cancer: an open-label, randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-28032013005000001

Standard triple, bismuth pectin quadruple and sequential therapies for Helicobacter pylori eradication

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-28032013005000001

Definition, diagnosis and treatment of immune thrombocytopenic purpura

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-28032013005000001

Meta-analysis: Helicobacter pylori eradication therapy vs. antisecretory non-eradication therapy for the prevention of recurrent bleeding from peptic ulcer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-28032013005000001

Review article: 13C-urea breath test in the diagnosis of Helicobacter pylori infection -- a critical review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-28032013005000001

Helicobacter pylori first-line treatment and rescue options in patients allergic to penicillin

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-28032013005000001

Accuracy of Helicobacter pylori diagnostic tests in patients with bleeding peptic ulcer: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-28032013005000001

Systematic review and meta-analysis: levofloxacin-based rescue regimens after Helicobacter pylori treatment failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-28032013005000001

Empirical rescue therapy after Helicobacter pylori treatment failure: a 10-year single-centre study of 500 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-28032013005000001

Helicobacter pylori first-line treatment and rescue option containing levofloxacin in patients allergic to penicillin

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-28032013005000001

Analysis of antimicrobial susceptibility and virulence factors in Helicobacter pylori clinical isolates

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-28032013005000001

Meat intake and risk of stomach and esophageal adenocarcinoma within the European Prospective Investigation Into Cancer and Nutrition (EPIC)

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-28032013005000001

Fruit and vegetable intake and the risk of stomach and oesophagus adenocarcinoma in the European Prospective Investigation into Cancer and Nutrition (EPIC-EURGAST).

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-28032013005000001

Furazolidone in Helicobacter pylori therapy: misunderstood and often unfairly maligned drug told in a story of French bread

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-28032013005000001

Studies regarding the mechanism of false negative urea breath tests with proton pump inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-28032013005000001

Twice daily (mid-day and evening) quadruple therapy for H. pylori infection in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-28032013005000001

14-day triple, 5-day concomitant, and 10-day sequential therapies for Helicobacter pylori infection in seven Latin American sites: a randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-28032013005000001

The response of Asian patients with functional dyspepsia to eradication of Helicobacter pylori infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-28032013005000001

Long-term proton pump inhibitor administration worsens atrophic corpus gastritis and promotes adenocarcinoma development in Mongolian gerbils infected with Helicobacter pylori.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-28032013005000001

Clinical trial: prolonged beneficial effect of Helicobacter pylori eradication on dyspepsia consultations - the Bristol Helicobacter Project

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-28032013005000001

Accurate diagnosis of Helicobacter pylori. Serologic testing

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-28032013005000001

Polymorphisms in Th1-type cell-mediated response genes and risk of gastric cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-28032013005000001

Role of Helicobacter pylori infection and non-steroidal anti-inflammatory drugs in peptic-ulcer disease: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-28032013005000001

Iron deficiency anaemia can be improved after eradication of Helicobacter pylori

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-28032013005000001

Gastric atrophy and risk of oesophageal cancer and gastric cardia adenocarcinoma--a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-28032013005000001

Meta-analysis: sequential therapy appears superior to standard therapy for Helicobacter pylori infection in patients naive to treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-28032013005000001

Systematic review and meta-analysis from Chinese literature: the association between Helicobacter pylori eradication and improvement of functional dyspepsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-28032013005000001

13 C-urea breath test with infrared spectroscopy for diagnosing helicobacter pylori infection in children and adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-28032013005000001

Furazolidone-based triple therapy for H pylori gastritis in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-28032013005000001

Decrease in prevalence of Helicobacter pylori infection during a 10-year period in Brazilian children

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-28032013005000001

Risk of aspirin-associated major upper-gastrointestinal bleeding with enteric-coated or buffered product.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-28032013005000001

Review article: current treatment options and management of functional dyspepsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-28032013005000001

Long-term follow-up in atrophic body gastritis patients: atrophy and intestinal metaplasia are persistent lesions irrespective of Helicobacter pylori infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-28032013005000001

Lansoprazole for the prevention of recurrences of ulcer complications from long-term low-dose aspirin use

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-28032013005000001

Prospective comparison of H&E, Giemsa, and Genta stains for the diagnosis of Helicobacter pylori

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-28032013005000001

Helicobacter pylori increases the risk of upper gastrointestinal bleeding in patients taking low-dose aspirin

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-28032013005000001

Low-dose aspirin and upper gastrointestinal damage: epidemiology, prevention and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-28032013005000001

Treatment options for Helicobacter pylori infection when proton pump inhibitor-based triple therapy fails in clinical practice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-28032013005000001

Factors predicting progression of gastric intestinal metaplasia: results of a randomised trial on Helicobacter pylori eradication

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-28032013005000001

Helicobacter pylori eradication and gastric preneoplastic conditions: a randomized, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-28032013005000001

Advantages of Moxifloxacin and Levofloxacin-based triple therapy for second-line treatments of persistent Helicobacter pylori infection: a meta analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-28032013005000001

Clarithromycin-resistant Helicobacter pylori in Recife, Brazil, directly identified from gastric biopsies by polymerase chain reaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-28032013005000001

Levofloxacin-based and clarithromycin-based triple therapies as first-line and second-line treatments for Helicobacter pylori infection: a randomised comparative trial with crossover design.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-28032013005000001

Maintenance treatment is not necessary after Helicobacter pylori eradication and healing of bleeding peptic ulcer: a 5-year prospective, randomized, controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-28032013005000001

Meta-analysis: gastrointestinal bleeding due to interaction between selective serotonin uptake inhibitors and non-steroidal anti-inflammatory drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-28032013005000001

Empiric quadruple vs. triple therapy for primary treatment of Helicobacter pylori infection: Systematic review and meta-analysis of efficacy and tolerability

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-28032013005000001

Furazolidone, tetracycline and omeprazole: a low-cost alternative for Helicobacter pylori eradication in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-28032013005000001

Predictors of long-term outcome of functional dyspepsia and duodenal ulcer after successful Helicobacter pylori eradication--a 7-year follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-28032013005000001

Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-28032013005000001

Helicobacter pylori eradication with a capsule containing bismuth subcitrate potassium, metronidazole, and tetracycline given with omeprazole versus clarithromycin-based triple therapy: a randomised, open-label, non-inferiority, phase 3 trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-28032013005000001

Management of Helicobacter pylori infection--the Maastricht IV/ Florence Consensus Report

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-28032013005000001

Exposure to foodborne and orofecal microbes versus airborne viruses in relation to atopy and allergic asthma: epidemiological study

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-28032013005000001

Helicobacter pylori eradication in functional dyspepsia: HEROES trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-28032013005000001

Helicobacter pylori and antibiotic resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-28032013005000001

Helicobacter pylori detection and antimicrobial susceptibility testing

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-28032013005000001

Seroprevalence of Helicobacter pylori antibodies in medical students and residents in Recife, Brazil

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-28032013005000001

Long term follow up of patients treated for Helicobacter pylori infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-28032013005000001

Seroprevalence of Helicobacter pylori infection among children of low socioeconomic level in São Paulo

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-28032013005000001

Asian consensus report on functional dyspepsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-28032013005000001

Helicobacter pylori eradication does not exacerbate reflux symptoms in gastroesophageal reflux disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-28032013005000001

Can the clinical history distinguish between organic and functional dyspepsia?

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-28032013005000001

The health economics of Helicobacter pylori infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-28032013005000001

Gastric precancerous lesions and Helicobacter pylori infection in relatives of gastric cancer patients from Northeastern Brazil

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-28032013005000001

Helicobacter pylori infection and iron stores: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-28032013005000001

A case-control study of gastric cancer in Venezuela

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-28032013005000001

Strategy for retreatment of therapeutic failure of eradication of Helicobacter pylori infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-28032013005000001

Effect of early eradication on Helicobacter pylori-related gastric carcinogenesis in Mongolian gerbils.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-28032013005000001

Observer agreement on the grading of gastric atrophy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-28032013005000001

Improvement in atrophic gastritis and intestinal metaplasia in patients in whom Helicobacter pylori was eradicated

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-28032013005000001

Comparison of the Etest and the NCCLS-approved agar dilution method to detect metronidazole and clarithromycin resistant Helicobacter pylori

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-28032013005000001

Helicobacter pylori infection and gastric lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-28032013005000001

Helicobacter pylori infection and the prevention of peptic ulcer with proton pump inhibitors in elderly subjects taking low-dose aspirin

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-28032013005000001

Helicobacter pylori primary resistance to metronidazole and clarithromycin in Brazil

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-28032013005000001

Natural history of Helicobacter pylori infection in childhood: eight-year follow-up cohort study in an urban community in northeast of Brazil

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-28032013005000001

Asthma is inversely associated with Helicobacter pylori status in an urban population

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-28032013005000001

Immunoblotting for the serodiagnosis of Helicobacter pylori infection in Brazilian patients with and without gastric carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-28032013005000001

History of breastfeeding and Helicobacter pylori infection in children: results of a community-based study from northeastern Brazil

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-28032013005000001

High eradication rates of Helicobacter pylori infection with first- and second-line combination of esomeprazole, tetracycline, and metronidazole in patients allergic to penicillin

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-28032013005000001

The long-term impact of Helicobacter pylori eradication on gastric histology: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-28032013005000001

Cumulative H. pylori eradication rates in clinical practice by adopting first and second-line regimens proposed by the Maastricht III consensus and a third-line empirical regimen

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-28032013005000001

Helicobacter pylori infection and gastric histology in first-degree relatives of gastric cancer patients: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-28032013005000001

Histological identification of Helicobacter pylori: comparison of staining methods

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-28032013005000001

Gastritis staging in clinical practice: the OLGA staging system

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-28032013005000001

EGILS consensus report. Gastric extranodal marginal zone B-cell lymphoma of MALT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-28032013005000001

Effect of Helicobacter pylori treatment on gastroesophageal reflux disease (GERD): meta-analysis of randomized controlled trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-28032013005000001

Levofloxacin-based triple therapy versus bismuth-based quadruple therapy for persistent Helicobacter pylori infection: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-28032013005000001

Failure of Helicobacter pylori treatment after regimes containing clarithromycin: new practical therapeutic options.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-28032013005000001

Recurrence of early gastric cancer. Follow-up of 1475 patients and review of the Japanese literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-28032013005000001

Prevalence of Helicobacter pylori infection and associated factors among adults in Southern Brazil: a population-based cross-sectional study

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-28032013005000001

ABC of the upper gastrointestinal tract: Indigestion and non-steroidal anti-inflammatory drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-28032013005000001

Helicobacter pylori: diagnosis and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-28032013005000001

Impact of lymph node metastasis on survival with early gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-28032013005000001

Validation of a rapid stool antigen test for diagnosis of Helicobacter pylori infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-28032013005000001

Gastric stump carcinoma - epidemiology and current concepts in pathogenesis and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-28032013005000001

Home environment and severe asthma in adolescence: a population based case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-28032013005000001

Functional gastroduodenal disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-28032013005000001

The effect of eradicating helicobacter pylori on the development of gastric cancer in patients with peptic ulcer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-28032013005000001

Meta-analysis: the effect of supplementation with probiotics on eradication rates and adverse events during Helicobacter pylori eradication therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-28032013005000001

Comparison of the clinical feasibility of three rapid urease tests in the diagnosis of Helicobacter pylori infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-28032013005000001

Helicobacter pylori infection and the development of gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-28032013005000001

Meta-analysis: role of Helicobacter pylori eradication in the prevention of peptic ulcer in NSAID users

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-28032013005000001

Gastric atrophy and intestinal metaplasia before and after Helicobacter pylori eradication: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-28032013005000001

Regulation of p53 tumor suppressor by Helicobacter pylori in gastric epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-28032013005000001

Peptic ulcer bleeding: accessory risk factors and interactions with non-steroidal anti-inflammatory drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-28032013005000001

Helicobacter pylori eradication to prevent gastric cancer in a high-risk region of China: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-28032013005000001

Helicobacter pylori-associated gastritis and primary B-cell gastric lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-28032013005000001

Is there an increased risk of GERD after Helicobacter pylori eradication?: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-28032013005000001

Randomized double-blind factorial trial of three treatments to reduce the prevalence of precancerous gastric lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-28032013005000001

Iron deficiency anemia in Helicobacter pylori infection: meta-analysis of randomized controlled trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-28032013005000001

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-28032013005000001

Effects of Helicobacter pylori eradication on early stage gastric mucosa-associated lymphoid tissue lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-28032013005000001

Furazolidone-based therapies for Helicobacter pylori infection: a pooled-data analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-28032013005000001

High eradication rates of Helicobacter pylori with a new sequential treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-28032013005000001

Helicobacter pylori and lung function, asthma, atopy and allergic disease--A population-based cross-sectional study in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-28032013005000001

Family history of cancer and stomach cancer risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-28032013005000001

Stomach cancer risk in gastric cancer relatives: interaction between Helicobacter pylori infection and family history of gastric cancer for the risk of stomach cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-28032013005000001

Sequential Therapy versus Standard Triple-Drug Therapy for Helicobacter pylori Eradication

21 January 2018

1 reference

https://api.crossref.org/works/10.1590%2FS0004-28032013005000001

Eradication of Helicobacter pylori for non-ulcer dyspepsia

21 January 2018

1 reference

COCI

https://opencitations.net/index/api/v1/citations/10.1002/14651858.CD002096.PUB4

10.1590/S0004-28032013005000001

12 January 2024

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23748591%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

1 reference